175 related articles for article (PubMed ID: 23504335)
21. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma.
Liu S; Shi L; Yang X; Ye D; Wang T; Dong C; Guo W; Liao Y; Song H; Xu D; Hu J; Zhang Z; Deng J
Cell Cycle; 2017 May; 16(9):894-902. PubMed ID: 28384094
[TBL] [Abstract][Full Text] [Related]
22. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis.
Shinozuka K; Uzawa K; Fushimi K; Yamano Y; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Oncology; 2009; 76(6):387-97. PubMed ID: 19407471
[TBL] [Abstract][Full Text] [Related]
24. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
World J Surg Oncol; 2012 Feb; 10():40. PubMed ID: 22336657
[TBL] [Abstract][Full Text] [Related]
26. Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer.
Webber LP; Wagner VP; Curra M; Vargas PA; Meurer L; Carrard VC; Squarize CH; Castilho RM; Martins MD
Histopathology; 2017 Aug; 71(2):278-286. PubMed ID: 28326594
[TBL] [Abstract][Full Text] [Related]
27. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic mechanisms in oral carcinogenesis.
Gasche JA; Goel A
Future Oncol; 2012 Nov; 8(11):1407-25. PubMed ID: 23148615
[TBL] [Abstract][Full Text] [Related]
29. Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
Harada Y; Izumi H; Noguchi H; Kuma A; Kawatsu Y; Kimura T; Kitada S; Uramoto H; Wang KY; Sasaguri Y; Hijioka H; Miyawaki A; Oya R; Nakayama T; Kohno K; Yamada S
Tumour Biol; 2016 Jan; 37(1):1357-68. PubMed ID: 26296622
[TBL] [Abstract][Full Text] [Related]
30. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
31. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma.
Lin CY; Jeng YM; Chou HY; Hsu HC; Yuan RH; Chiang CP; Kuo MY
J Surg Oncol; 2008 May; 97(6):544-50. PubMed ID: 18297688
[TBL] [Abstract][Full Text] [Related]
32. DNA replication licensing factor MCM2, geminin, and Ki67 define proliferative state and are linked with survival in oral squamous cell carcinoma.
Al-Hazmi N; Alhazzazi T; Williams G; Stoeber K; Al-Dabbagh R
Eur J Oral Sci; 2018 Jun; 126(3):186-196. PubMed ID: 29745471
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma.
Ma HL; Jin SF; Tao WJ; Zhang ML; Zhang ZY
J Craniomaxillofac Surg; 2016 Oct; 44(10):1725-1732. PubMed ID: 27591090
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome.
Jiang Q; Pan HY; Ye DX; Zhang P; Zhong LP; Zhang ZY
Tumour Biol; 2010 Oct; 31(5):451-9. PubMed ID: 20532727
[TBL] [Abstract][Full Text] [Related]
35. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
36. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
37. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
Cai L; Ma X; Huang Y; Zou Y; Chen X
Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
Naruse T; Kawasaki G; Yanamoto S; Mizuno A; Umeda M
Anticancer Res; 2011 Dec; 31(12):4429-37. PubMed ID: 22199311
[TBL] [Abstract][Full Text] [Related]
40. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
